Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB.

Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB. Int Urogynecol J. 2012 Aug; 23(8):1017-25.

View in: PubMed

subject areas

Activities of Daily Living
Botulinum Toxins, Type A
Double-Blind Method
Female
Humans
Male
Middle Aged
Patient Satisfaction
Quality of Life
Surveys and Questionnaires
Treatment Outcome
Urinary Bladder, Overactive
Urinary Incontinence

authors with profiles

Peter Sand